In conclusion, this study found that patients with HNSCC or NPC and type 2 diabetes requiring insulin at baseline are at high risk of life-threatening diabetes-related complications whilst undergoing CCRT, particularly if enteral feeding is initiated. This evidence concerns the gene INS and head and neck squamous cell carcinoma.